Talence, France

Patrick Mahy


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Patrick Mahy: Innovator in Nucleic Acid Compositions

Introduction

Patrick Mahy is a notable inventor based in Talence, France. He has made significant contributions to the field of biotechnology, particularly in the development of compositions that incorporate nucleic acids. His innovative work has implications for pharmaceuticals, especially in gene therapy.

Latest Patents

Patrick Mahy holds a patent for a composition that contains a plurality of multicellular vesicles and at least one nucleic acid. This composition features multilamellar vesicles, where at least one part of the nucleic acid is included inside these vesicles. The vesicles are constructed from concentric lamellar bi-layers that extend from the center to the periphery, incorporating at least one surfactant agent. The bi-layers are separated by a liquid medium, making these compositions particularly useful in pharmaceutics, including applications in gene therapy and transfection both in vitro and in vivo. He has 1 patent to his name.

Career Highlights

Patrick Mahy is associated with Capsulis, a company that focuses on innovative solutions in the field of biotechnology. His work at Capsulis has allowed him to explore and develop groundbreaking technologies that enhance the delivery of nucleic acids for therapeutic purposes.

Collaborations

Throughout his career, Patrick has collaborated with esteemed colleagues such as Didier Roux and René Laversanne. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Patrick Mahy is a distinguished inventor whose work in nucleic acid compositions has the potential to revolutionize gene therapy and pharmaceutical applications. His contributions to the field are noteworthy and continue to inspire innovation in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…